SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-14-008677
Filing Date
2014-10-30
Accepted
2014-10-30 07:08:48
Documents
13
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2221837z10-q.htm 10-Q 450949
2 EX-31.1 a2221837zex-31_1.htm EX-31.1 7722
3 EX-31.2 a2221837zex-31_2.htm EX-31.2 7699
4 EX-32.1 a2221837zex-32_1.htm EX-32.1 4442
5 EX-32.2 a2221837zex-32_2.htm EX-32.2 4422
6 EX-99.1 a2221837zex-99_1.htm EX-99.1 99558
13 G214683MM05I001.JPG g214683mm05i001.jpg GRAPHIC 2041
  Complete submission text file 0001047469-14-008677.txt   5148522

Data Files

Seq Description Document Type Size
7 EX-101.INS vstm-20140930.xml EX-101.INS 981751
8 EX-101.SCH vstm-20140930.xsd EX-101.SCH 25904
9 EX-101.CAL vstm-20140930_cal.xml EX-101.CAL 49853
10 EX-101.DEF vstm-20140930_def.xml EX-101.DEF 95553
11 EX-101.LAB vstm-20140930_lab.xml EX-101.LAB 300811
12 EX-101.PRE vstm-20140930_pre.xml EX-101.PRE 187633
Mailing Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142 617-252-9300
Verastem, Inc. (Filer) CIK: 0001526119 (see all company filings)

IRS No.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35403 | Film No.: 141181552
SIC: 2834 Pharmaceutical Preparations